Share capital, share premium and transaction costs on new equity instruments - Additional Information (Detail)
€ / shares in Units, $ / shares in Units, $ in Thousands |
|
|
|
|
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
|
Oct. 18, 2023
EUR (€)
warrants
€ / shares
shares
|
Oct. 03, 2023
EUR (€)
warrants
€ / shares
shares
|
Aug. 10, 2023
EUR (€)
€ / shares
shares
|
Jun. 09, 2023
EUR (€)
€ / shares
shares
|
Jul. 28, 2022
EUR (€)
shares
|
Jul. 28, 2022
USD ($)
shares
|
Apr. 15, 2022
EUR (€)
€ / shares
shares
|
Mar. 22, 2022
EUR (€)
€ / shares
shares
|
Mar. 16, 2022
EUR (€)
€ / shares
shares
|
Oct. 18, 2023
EUR (€)
shares
€ / shares
|
Dec. 31, 2023
EUR (€)
€ / shares
shares
|
Dec. 31, 2022
EUR (€)
€ / shares
shares
|
Dec. 31, 2022
EUR (€)
shares
€ / shares
|
Dec. 31, 2022
EUR (€)
warrants
€ / shares
shares
|
Dec. 31, 2021
EUR (€)
€ / shares
shares
|
May 16, 2022
EUR (€)
|
Jul. 28, 2021
€ / shares
|
Jul. 28, 2021
$ / shares
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issued capital |
|
|
|
|
|
|
|
|
|
|
€ 32,521,000
|
€ 32,061,000
|
€ 32,061,000
|
€ 32,061,000
|
|
|
|
|
| Par value per share (in EUR per share) | € / shares |
|
|
|
|
|
|
€ 0.12
|
€ 0.12
|
€ 0.12
|
|
|
€ 0.12
|
€ 0.12
|
€ 0.12
|
|
|
|
|
| Equity contribution (PIPE financing) |
|
|
|
|
|
|
|
|
|
|
(955,000)
|
|
|
|
|
|
|
|
| Share Capital increase on conversion (in shares) | shares |
|
|
|
|
|
|
|
|
235,935,061
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, number of securities called by each warrant or right (in shares) | shares |
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through exchange of ordinary shares (in shares) | shares |
|
|
|
|
|
|
|
|
14,907,582
|
|
|
|
|
|
|
|
|
|
| Equity contribution (Spartan shareholders) |
|
|
|
|
|
|
|
|
€ 87,597,000
|
|
|
€ 87,597,000
|
|
|
|
|
|
|
| Shares issued in the period (in shares) | shares |
|
|
|
|
|
|
|
2,500,000
|
12,500,000
|
|
|
|
|
|
|
|
|
|
| Contract liabilities |
|
|
|
|
|
|
|
|
|
|
10,003,000
|
10,359,000
|
€ 10,359,000
|
€ 10,359,000
|
|
|
|
|
| Share issue related cost |
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
|
€ 1,059,000
|
|
|
|
| Private Placement Warrants exercise (in shares) | shares |
|
|
|
|
|
|
1,334,949
|
|
|
|
|
|
|
|
|
|
|
|
| Equity contribution (Private placement warrants exercise) |
|
|
|
|
|
|
|
|
|
|
€ 7,569,000
|
€ 13,854,000
|
|
|
|
|
|
|
| Number of shares issued (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
271,010,790
|
267,177,592
|
267,177,592
|
267,177,592
|
190,270,211
|
|
|
|
| Private Placement Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants assumed on transaction date (shares) |
|
|
|
|
|
|
|
|
|
|
|
|
9,360,000
|
9,360,000
|
|
|
|
|
| Public Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Par value per share (in EUR per share) | € / shares |
€ 0.12
|
€ 0.12
|
|
|
|
|
|
|
|
€ 0.12
|
|
|
|
|
|
|
|
|
| Shares issued in the period (in shares) | shares |
159,712
|
2,996,918
|
|
|
|
|
|
|
|
3,156,630
|
|
|
|
|
|
|
|
|
| Warrants assumed on transaction date (shares) |
770,110
|
13,029,838
|
|
|
|
|
|
|
|
13,799,948
|
|
|
13,799,948
|
13,799,948
|
|
|
|
|
| PIPE financing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity contribution (PIPE financing) |
|
|
|
|
|
|
|
|
|
|
|
€ 132,690,000
|
|
|
|
|
|
|
| Shares issued in the period (in shares) | shares |
|
|
|
|
15,000,000
|
15,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Price per share (in EURO per share) | (per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
€ 9.07
|
$ 10.00
|
| Proceeds from issuing equity instruments |
|
|
|
|
€ 136,048,000
|
$ 150,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Contract liabilities |
|
|
|
|
|
|
|
|
|
|
€ 2,906,000
|
3,358,000
|
€ 3,358,000
|
€ 3,358,000
|
|
€ 3,358,000
|
|
|
| General and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based payment expenses - SPAC Transaction |
|
|
|
|
|
|
|
|
€ 158,714,000
|
|
0
|
158,714,000
|
|
|
€ 0
|
|
|
|
| Share capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through conversion of convertible instruments, equity |
|
|
|
|
|
|
|
|
28,311,000
|
|
|
|
|
|
|
|
|
|
| Share premium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through conversion of convertible instruments, equity |
|
|
|
|
|
|
|
|
(28,311,000)
|
|
|
|
|
|
|
|
|
|
| Equity contribution (PIPE financing) |
|
|
|
|
|
|
|
€ 22,375,000
|
108,515,000
|
|
(955,000)
|
|
|
|
|
|
|
|
| Equity contribution (Spartan shareholders) |
|
|
|
|
|
|
|
|
85,808,000
|
|
|
85,808,000
|
|
|
|
|
|
|
| Share issue related cost |
|
|
|
|
|
|
|
|
|
|
955,000
|
|
|
|
€ 1,059,000
|
|
|
|
| Equity contribution (Private placement warrants exercise) |
|
|
|
|
|
|
€ 13,694,000
|
|
|
|
7,190,000
|
13,694,000
|
|
|
|
|
|
|
| Share premium | Public Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity contribution (Private placement warrants exercise) |
€ 252,000
|
€ 6,938,000
|
|
|
|
|
|
|
|
€ 7,190,000
|
|
|
|
|
|
|
|
|
| Share premium | PIPE financing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity contribution (PIPE financing) |
|
|
|
|
|
|
|
|
|
|
|
130,890,000
|
|
|
|
|
|
|
| Share capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through conversion of convertible instruments, equity |
|
|
|
|
|
|
|
|
28,311,000
|
|
|
|
|
|
|
|
|
|
| Equity contribution (PIPE financing) |
|
|
|
|
|
|
|
€ 300,000
|
1,500,000
|
|
0
|
|
|
|
|
|
|
|
| Equity contribution (Spartan shareholders) |
|
|
|
|
|
|
|
|
€ 1,789,000
|
|
|
1,789,000
|
|
|
|
|
|
|
| Equity contribution (Private placement warrants exercise) |
|
|
|
|
|
|
€ 160,000
|
|
|
|
379,000
|
160,000
|
|
|
|
|
|
|
| Share capital | Public Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity contribution (Private placement warrants exercise) |
€ 19,000
|
€ 360,000
|
|
|
|
|
|
|
|
€ 379,000
|
|
|
|
|
|
|
|
|
| Share capital | PIPE financing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity contribution (PIPE financing) |
|
|
|
|
|
|
|
|
|
|
|
€ 1,800,000
|
|
|
|
|
|
|
| Allego Holding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Par value per share (in EUR per share) | € / shares |
|
|
|
|
|
|
|
|
€ 1.00
|
|
|
€ 1.00
|
€ 1.00
|
€ 1.00
|
€ 1.00
|
|
|
|
| Shareholder loan to equity conversion (in shares) | shares |
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
| Number of shares issued in the fee agreement (in shares) | shares |
|
|
|
|
|
|
|
|
22
|
|
|
|
|
|
|
|
|
|
| Number of shares exchanged for shares in new company (in share) | shares |
|
|
|
|
|
|
|
|
124
|
|
|
|
|
|
|
|
|
|
| Number of shares issued (in shares) | shares |
|
|
|
|
|
|
|
|
124
|
|
|
100
|
100
|
100
|
100
|
|
|
|
| Allego Holding | Share capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholder loan equity conversion |
|
|
|
|
|
|
|
|
€ 2
|
|
|
|
|
|
|
|
|
|
| Allego Holding | Share premium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) through conversion of convertible instruments, equity |
|
|
|
|
|
|
|
|
101,931,000
|
|
|
|
|
|
|
|
|
|
| Share issue related cost |
|
|
|
|
|
|
|
|
|
|
|
€ 1,059,000
|
|
|
|
|
|
|
| Allego Holding | Share capital |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity contribution (PIPE financing) |
|
|
|
|
|
|
|
|
€ 22
|
|
|
|
|
|
|
|
|
|
| Long-term Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares issued (in shares) | shares |
|
|
666,968
|
9,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from issuing shares |
|
|
€ 0
|
€ 0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issued capital |
|
|
|
|
|
|
|
|
|
|
€ 32,521,000
|
€ 32,061,000
|
€ 32,061,000
|
€ 32,061,000
|
|
|
|
|
| Number of shares outstanding (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
271,010,790
|
267,177,592
|
267,177,592
|
267,177,592
|
|
|
|
|
| Par value per share (in EUR per share) | € / shares |
|
|
|
|
|
|
|
|
|
|
€ 0.12
|
€ 0.12
|
€ 0.12
|
€ 0.12
|
|
|
|
|
| Authorized capital |
|
|
|
|
|
|
|
|
|
|
€ 108,000,000
|
€ 108,000,000
|
€ 108,000,000
|
€ 108,000,000
|
|
|
|
|
| Number of shares authorised | shares |
|
|
|
|
|
|
|
|
|
|
900,000,000
|
900,000,000
|
900,000,000
|
900,000,000
|
|
|
|
|
| Share issue related cost |
|
|
|
|
|
|
|
|
|
|
€ 955,000
|
€ 0
|
|
|
|
|
|
|
| Ordinary Shares | Private Placement Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Par value per share (in EUR per share) | € / shares |
|
|
|
|
|
|
|
|
|
|
€ 0.12
|
|
|
|
|
|
|
|
| Ordinary Shares | Public Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of warrant or right, number of securities called by each warrant or right (in shares) | shares |
|
|
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
|
|
| Ordinary Shares | Long-term Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share Capital, Share Premium and Transaction Costs On New Equity Instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Par value per share (in EUR per share) | € / shares |
|
|
€ 0.12
|
€ 0.12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|